0000950170-24-069549.txt : 20240605
0000950170-24-069549.hdr.sgml : 20240605
20240605200003
ACCESSION NUMBER: 0000950170-24-069549
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240603
FILED AS OF DATE: 20240605
DATE AS OF CHANGE: 20240605
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Grossman Fred
CENTRAL INDEX KEY: 0001985154
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41583
FILM NUMBER: 241023567
MAIL ADDRESS:
STREET 1: C/O COYA THERAPEUTICS, INC.
STREET 2: 5850 SAN FELIPE ST., SUITE 500
CITY: HOUSTON
STATE: TX
ZIP: 77057
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Coya Therapeutics, Inc.
CENTRAL INDEX KEY: 0001835022
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12645 MEMORIAL DR., SUITE F1 #305
CITY: HOUSTON
STATE: TX
ZIP: 77024
BUSINESS PHONE: 650.739.3939
MAIL ADDRESS:
STREET 1: 12645 MEMORIAL DR., SUITE F1 #305
CITY: HOUSTON
STATE: TX
ZIP: 77024
4
1
ownership.xml
4
X0508
4
2024-06-03
0001835022
Coya Therapeutics, Inc.
COYA
0001985154
Grossman Fred
5850 SAN FELIPE ST.,
SUITE 500
HOUSTON
TX
77057
false
true
false
false
Chief Medical Officer
false
Stock Option (right to buy)
8.15
2024-06-03
4
A
false
70596
0
A
2034-06-03
Common Stock
70596
70596
D
Subject to continuous service, the shares subject to the option vest in equal monthly installments over a period of 36 months, commencing on July 3, 2024.
/s/ David Snyder, Attorney-in-Fact
2024-06-05